TERN
TERN
NASDAQ · Pharmaceuticals

Terns Pharmaceuticals Inc

Mid-Cap Stocks Pharmaceutical Stocks Healthcare Stocks
$52.95
+0.00 (+0.00%)
As of Sep 12, 1:27 AM ET ·
Analyst Consensus
Hold
17
Analysts
High
Coverage
Buy 6 35%
Hold 11 65%
Sell 0 0%
Price Target
Analyst Price Target -29.8% upside
Low Target $32.00
Average Target $37.17
High Target $56.15
Current Price $52.95
Current
$52.95
Target
$37.17
$32.00 $37.17 avg $56.15
Scenario Analysis
Bear Case
$32.00
-39.6%
Low target
Base Case
$37.17
-29.8%
Avg target
Bull Case
$56.15
+6.0%
High target
Risk/Reward
0.2x
Unfavorable
Price in Context
52-Week High
$53.19
-0.5% from high
52-Week Low
$6.99
+658.1% from low
50-Day SMA
$38.73
+36.7% vs SMA
200-Day SMA
$16.20
+226.9% vs SMA
RSI (14)
69.0
Neutral
Target vs 52W High
$37.17
-30.1% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
 Strong Buy 38 79% $1,330.33 +13.7%
RDY
Dr. Reddy's Laboratories
 Strong Sell 45 31% — +0.0%
JNJ
Johnson & Johnson
 Buy 31 71% $299.55 +11.3%
MRK
Merck & Co. Inc.
 Buy 36 72% $159.27 +5.5%
PFE
Pfizer Inc.
 Hold 36 39% $33.90 +21.4%
BMY
Bristol-Myers Squibb Co
 Hold 35 43% $174.50 +180.3%
RPRX
Royalty Pharma Plc- Cl A
 Strong Buy 16 88% $36.26 -38.0%
ZTS
Zoetis Inc
 Hold 24 50% $209.87 +188.0%